Pfizer director acquires 1,744 deferred stock units
The deferred compensation units are settled in cash or common stock at the director’s election following retirement from the board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pfizer Inc. director Shantanu Narayen acquired 1,743.9830 Phantom Stock Units on September 25, 2026; the transaction lists $28.6700 per unit. The units represent deferred director's compensation, including dividend equivalents. Their terms provide for settlement in cash or common stock at his election following retirement from the Board. Narayen directly held 205,648.8230 Phantom Stock Units after the transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units F1, F2 | 1,743.983 | $28.67 | $50K |
Footnotes (2)
- F1. Each unit represents one phantom share of common stock.
- F2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Key Figures
Key Terms
Phantom Stock Units financial
deferred director's compensation financial
dividend equivalents financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many Phantom Stock Units did PFE director Shantanu Narayen acquire?
What does one PFE Phantom Stock Unit represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.